🇺🇸 FDA
Patent

US 12144890

Manufacturing of bupivacaine multivesicular liposomes

granted A61KA61K31/451A61K9/0019

Quick answer

US patent 12144890 (Manufacturing of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/451, A61K9/0019, A61K9/1277